TTOO
T2 Biosystems, Inc.
0.0130
+0.0000+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
364.59K
P/E (TTM)
-
Basic EPS (TTM)
-0.03
Dividend Yield
0%

Recent Filings

About 

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

CEO
Mr. Craig R. Jalbert CIRA
IPO
8/7/2014
Website
https://investors.t2biosystems.com
Employees
113
Sector
Healthcare
Industry
Diagnostics & Research

Related Companies  

BIAF
bioAffinity Technologies, Inc.
1.38-0.10
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
IDXG
Interpace Biosciences, Inc.
1.14-0.02
ILMN
Illumina, Inc.
131.56-3.36
MEHCQ
CHROME HLDG CO
3.50+0.00
NEO
NeoGenomics, Inc.
11.67-0.25
PRPO
Precipio, Inc.
24.02-0.04
TMO
Thermo Fisher Scientific Inc
570.16-5.75
TWST
Twist Bioscience Corporation
31.13+0.06
WGS
GeneDx Holdings Corp.
141.72-8.89